Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017)
Aquestive Therapeutics (AQST) posted quarterly Preferred Dividend Payments of $626000.0 for Q4 2017, little changed quarter-over-quarter from $626000.0 in Q3 2017.
Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017) Analysis & Trends
Aquestive Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $626000.0 for Q4 2017.
- In Q4 2017, Preferred Dividend Payments changed N/A year-over-year to $626000.0; the TTM figure through Dec 2018 stood at $626000.0 (changed N/A YoY), while the FY2017 annual figure was $2.5 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q4 2017 stood at $626000.0, roughly flat from $626000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $626000.0 in Q3 2017, with the low at $615000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aquestive Therapeutics | 558.10 Mn | 558.10 Mn | 9.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 626,000.00 |
| Sep 30, 2017 | 626,000.00 |
| Jun 30, 2017 | 615,000.00 |